Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Zydus Cadila Explores Orphan Drug Indication For NASH Candidate
Expects 20-25 New Product Launches In FY21
Feb 06 2020
•
By
Vibha Ravi
Cadila Explores More Indications For Its NASH Candidate • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Business
More from Scrip